Join this discussion on HLA-associated adverse drug reactions, an emerging consideration when prescribing high-risk medications. Titled “Genomic Red Flags: HLA’s Impact on Drug Safety,” this presentation will explore the classifications of adverse drug reactions, the essential role of HLA polymorphic genes in the human body, and the various drug-HLA associations. It will also explore approaches to diagnosis, management, and the growing importance of HLA screening as a preventative strategy shaping the future of healthcare. Highlighting emerging research, the presentation will underscore how preemptive HLA testing can significantly enhance patient outcomes for those at risk of HLA-associated adverse drug reactions.

Microsoft Teams Meeting link to join the live session: Join the meeting now

Speaker: Cassandra Caringella, PharmD, PGY1 Pharmacy Resident – Advocate Lutheran General Hospital 

Objectives: ​​ 

• Identify the history and function of Human Leukocyte Antigen (HLA) and the effect they have on the human body 
• Differentiate the classification of different adverse drug reactions 
• Assess HLA screening for high-risk medications and the role it plays in the patient care process 
• Recall specific medications and their adverse drug reactions in patients with atypical HLA genes 

Target Audience:​ Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals

Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.